WATCH TV LIVE

Skip to main content
NEWSMAX TV HEALTH MONEY WORLD
Tags: weight loss | medications | glp-1 | suicide risk | warning | fda

FDA: Remove GLP-1 Drug Suicide Warnings

magnifying glass "FDA"
(Dreamstime)

Tuesday, 13 January 2026 10:00 AM EST

The U.S. Food and Drug Administration on Tuesday ‍requested companies ‍to remove warnings related ⁠to the potential risk of suicidal ideation from ​the labeling of popular weight-loss drugs of ‍the GLP-1 class.

The action ⁠follows a comprehensive FDA review that found no increased risk of ⁠suicidal ​ideation ⁠and behavior associated with the ‍use of GLP-1 drugs, ‌which include Novo Nordisk's Wegovy and older ⁠drug ​Saxenda, ‍and Eli Lilly's Zepbound.

© 2026 Thomson/Reuters. All rights reserved.


Click Here to comment on this article
Share
Health-News
The U.S. Food and Drug Administration on Tuesday requested companies to remove warnings related ⁠to the potential risk of suicidal ideation from ​the labeling of popular weight-loss drugs of the GLP-1 class. The action ⁠follows a comprehensive FDA review that found no...
weight loss, medications, glp-1, suicide risk, warning, fda
69
2026-00-13
Tuesday, 13 January 2026 10:00 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
Apple
Android
Amazon
Samsung
Vizio
Roku
Sony
LG
Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved